The Pharmacodynamics of Antimicrobial Agents

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-08-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/9781118675014.CH5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies

  2012cited by this paper
• Pharmacodynamics of oxytetracycline administered alone and in combination with carprofen in calves

  2012cited by this paper
• The Biofilm-Specific Antibiotic Resistance Gene ndvB Is Important for Expression of Ethanol Oxidation Genes in Pseudomonas aeruginosa Biofilms

  2012cited by this paper
• Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia

  2011cited by this paper
• Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infection.

  2011cited by this paper
• Dogs Leaving the ICU Carry a Very Large Multi-Drug Resistant Enterococcal Population with Capacity for Biofilm Formation and Horizontal Gene Transfer

  2011cited by this paper
• Evaluation of Once-Daily Vancomycin against Methicillin-Resistant Staphylococcus aureus in a Hollow-Fiber Infection Model

  2011cited by this paper
• Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid

  2011cited by this paper
• Are pleuromutilin antibiotics finally fit for human use?

  2011cited by this paper
• Use of vancomycin pharmacokinetic–pharmacodynamic properties in the treatment of MRSA infections

  2010cited by this paper
• Investigation of mammary blood flow changes by transrectal colour Doppler sonography in an Escherichia coli mastitis model

  2010cited by this paper
• Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model

  2010cited by this paper
• Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

  2009cited by this paper
• Productive steps toward an antimicrobial targeting virulence.

  2009cited by this paper
• Effect of milk on antibacterial activity of tetracycline against Escherichia coli and Staphylococcus aureus isolated from bovine mastitis

  2009cited by this paper
• Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.

  2009cited by this paper
• Influence of Inoculum Size and Marbofloxacin Plasma Exposure on the Amplification of Resistant Subpopulations of Klebsiella pneumoniae in a Rat Lung Infection Model

  2009cited by this paper
• Functional relationship between bacterial cell density and the efficacy of antibiotics.

  2009cited by this paper
• The biology and future prospects of antivirulence therapies

  2008cited by this paper
• Bacterial persistence: some new insights into an old phenomenon

  2008cited by this paper
• In Vitro Antimicrobial Activity of a New Cephalosporin, Ceftaroline, and Determination of Quality Control Ranges for MIC Testing

  2008cited by this paper
• Inter-kingdom signalling: communication between bacteria and their hosts

  2008cited by this paper
• Enrichment of Fluoroquinolone-Resistant Staphylococcus aureus: Oscillating Ciprofloxacin Concentrations Simulated at the Upper and Lower Portions of the Mutant Selection Window

  2008cited by this paper
• Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine

  2008cited by this paper
• Setting and Revising Antibacterial Susceptibility Breakpoints

  2007cited by this paper
• The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis.

  2007cited by this paper
• Biofilms and their relevance to veterinary medicine.

  2007cited by this paper
• Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid

  2007cited by this paper
• Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.

  2007cited by this paper
• Influence of Inoculum Size on the Selection of Resistant Mutants of Escherichia coli in Relation to Mutant Prevention Concentrations of Marbofloxacin

  2007cited by this paper
• AUC/MIC: a PK/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor?

  2007cited by this paper
• Targeting virulence: a new paradigm for antimicrobial therapy

  2007cited by this paper
• Mutant selection window hypothesis updated.

  2007cited by this paper
• Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era.

  2007cited by this paper
• Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values.

  2006cited by this paper
• Low Correlation between MIC and Mutant Prevention Concentration

  2006cited by this paper
• Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.

  2006cited by this paper
• An integrated pharmacoeconomic approach to antimicrobial formulary decision-making.

  2006cited by this paper
• The Relationship between Quinolone Exposures and Resistance Amplification Is Characterized by an Inverted U: a New Paradigm for Optimizing Pharmacodynamics To Counterselect Resistance

  2006cited by this paper
• Increase of Microcirculatory Blood Flow Enhances Penetration of Ciprofloxacin into Soft Tissue

  2005cited by this paper
• Effective Antimicrobial Regimens for Use in Humans for Therapy of Bacillus anthracis Infections and Postexposure Prophylaxis

  2005cited by this paper
• Comparative Mutant Prevention Concentrations of Pradofloxacin and Other Veterinary Fluoroquinolones Indicate Differing Potentials in Preventing Selection of Resistance

  2005cited by this paper
• Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.

  2005cited by this paper
• Modeling physiological resistance in bacterial biofilms

  2005cited by this paper
• Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats.

  2005cited by this paper
• Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems.

  2005cited by this paper
• Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry.

  2005cited by this paper
• Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact.

  2005cited by this paper
• Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.

  2004cited by this paper
• Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue

  2004cited by this paper
• Pharmacodynamics of antimicrobial drugs.

  2004cited by this paper
• Virulence factors of the coagulase-negative staphylococci.

  2004cited by this paper
• The Changing Face of Antibiotic Prescribing: The Mutant Selection Window

  2004cited by this paper
• Population pharmacokinetics of marbofloxacin in horses: preliminary analysis.

  2004cited by this paper
• Ion-Trapping, Microsomal Binding, and Unbound Drug Distribution in the Hepatic Retention of Basic Drugs

  2004cited by this paper
• Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'

  2004cited by this paper
• Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli

  2004cited by this paper
• Persister cells and tolerance to antimicrobials.

  2004cited by this paper
• Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone

  2004cited by this paper
• Reduction of flobufen in pig hepatocytes: effect of pig breed (domestic, wild) and castration.

  2003cited by this paper
• Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

  2003cited by this paper
• Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy.

  2003cited by this paper
• Effects of dietary electrolyte balance on the chemistry of blood and urine in lactating sows and sow litter performance.

  2003cited by this paper
• Impact of pharmacodynamics on dosing of macrolides, azalides, and ketolides.

  2003cited by this paper
• A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance

  2003cited by this paper
• Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection.

  2002cited by this paper
• Has antifungal susceptibility testing come of age?

  2002cited by this paper
• Recent advances into the pathogenesis of recurrent urinary tract infections: the bladder as a reservoir for uropathogenic Escherichia coli.

  2002cited by this paper
• Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models.

  2002cited by this paper
• Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models

  2002cited by this paper
• Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.

  2002cited by this paper
• Mechanisms of antibiotic resistance in bacterial biofilms.

  2002cited by this paper
• Interstitial tissue concentrations of cefpodoxime.

  2002cited by this paper
• Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint

  2001cited by this paper
• Penicillin Pharmacodynamics in Four Experimental Pneumococcal Infection Models

  2001cited by this paper
• A Retrospective Analysis of Pharmacokinetic-Pharmacodynamic Parameters as Indicators of the Clinical Efficacy of Ceftizoxime

  2001cited by this paper
• Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates.

  2001cited by this paper
• Pharmacodynamics of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model of Infection

  2001cited by this paper
• Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time.

  2000cited by this paper
• Limitations of single point pharmacodynamic analysis.

  2000cited by this paper
• Bacterial virulence as a target for antimicrobial chemotherapy.

  2000cited by this paper
• Antibiotic efficacy in vivo predicted by in vitro activity.

  2000cited by this paper
• The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae.

  2000cited by this paper
• Prediction of the Effects of Inoculum Size on the Antimicrobial Action of Trovafloxacin and Ciprofloxacin againstStaphylococcus aureus and Escherichia coli in an In Vitro Dynamic Model

  1999cited by this paper
• Norfloxacin pharmacokinetics in lactating cows with sub-clinical and clinical mastitis.

  1999cited by this paper
• Effect of the Growth Rate of Pseudomonas aeruginosa Biofilms on the Susceptibility to Antimicrobial Agents: β-Lactams and Fluoroquinolones

  1999cited by this paper
• Bacterial biofilms: a common cause of persistent infections.

  1999cited by this paper
• Influences of Urinary pH on Ciprofloxacin Pharmacokinetics in Humans and Antimicrobial Activity In Vitro versus Those of Sparfloxacin

  1999cited by this paper
• Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells.

  1999cited by this paper
• Tobramycin penetration into epithelial lining fluid of patients with pneumonia

  1999cited by this paper
• Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.

  1998cited by this paper
• Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

  1998cited by this paper
• Bacterial concentrations in pus and infected peritoneal fluid--implications for bactericidal activity of antibiotics.

  1998cited by this paper
• Efficacy of doxycycline in feed for the control of pneumonia caused by Pasteurella multocida and Mycoplasma hyopneumoniae in fattening pigs

  1998cited by this paper
• In Vivo Activities of Amoxicillin and Amoxicillin-Clavulanate against Streptococcus pneumoniae: Application to Breakpoint Determinations

  1998cited by this paper
• A New Approach to In Vitro Comparisons of Antibiotics in Dynamic Models: Equivalent Area under the Curve/MIC Breakpoints and Equiefficient Doses of Trovafloxacin and Ciprofloxacin against Bacteria of Similar Susceptibilities

  1998cited by this paper
• Biofilms and beta-lactam activity.

  1998cited by this paper
• The effects of macrolides on the expression of bacterial virulence mechanisms.

  1998cited by this paper
• Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens.

  1998cited by this paper
• Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis.

  1997cited by this paper

• Pharmacokinetics and depletion of florfenicol in striped catfish Pangasianodon hypophthalmus after oral administration

  2023cites this paper
• Pharmacokinetics of Trimethoprim-Sulfamethoxazole in the Green Iguana (Iguana iguana)

  2022cites this paper
• Temperature has considerable effects on plasma and muscle antibiotic concentrations in Atlantic salmon (Salmo salar)

  2022cites this paper
• PK/PD Analysis of Marbofloxacin by Monte Carlo Simulation against Mycoplasma agalactiae in Plasma and Milk of Lactating Goats after IV, SC and SC-Long Acting Formulations Administration

  2021cites this paper
• Effects of Growth Medium and Inoculum Size on Pharmacodynamics Activity of Marbofloxacin against Staphylococcus aureus Isolated from Caprine Clinical Mastitis

  2021cites this paper
• Determination of the pharmacokinetic-pharmacodynamic cut-off values of marbofloxacin in horses to support the establishment of a clinical breakpoint for antimicrobial susceptibility testing.

  2020cites this paper
• Rational Antimicrobial Therapy

  2020cites this paper
• Antimicrobial agent use in small animals what are the prescribing practices, use of PK-PD principles, and extralabel use in the United States?

  2020cites this paper
• VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle

  2019cites this paper
• Effect of antibiotic treatment in preweaned Holstein calves after experimental bacterial challenge with Pasteurella multocida

  2019cites this paper
• S0950268818002510jra 1..6

  2019cites this paper
• Approaches to developing judicious uses of veterinary antibacterial drugs.

  2019cites this paper
• Acute puerperal metritis : antimicrobial therapy and the relationship between antimicrobial pharmacodynamics and therapeutic success

  2019cites this paper
• Assessing concentration of antibiotics in tissue during oral treatments against piscirickettsiosis.

  2018cites this paper
• Reduced susceptibility in leptospiral strains of bovine origin might impair antibiotic therapy

  2018cites this paper
• Swine enteric colibacillosis: diagnosis, therapy and antimicrobial resistance

  2017cites this paper
• An investigation of antimicrobial usage patterns by small animal veterinarians in South Africa.

  2017cites this paper
• The 2012 Antimicrobial Agents in Veterinary Medicine : exploring the consequences of antimicrobial drug use : a 3-D approach 1

  2017cites this paper
• En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach

  2017cites this paper
• Retrospective analysis of antibiotic treatments against piscirickettsiosis in farmed Atlantic salmon Salmo salar in Chile.

  2016cites this paper
• A survey of antimicrobial usage patterns by veterinarians treating dogs and cats in South Africa

  2015cites this paper
• Antimicrobial susceptibility testing for bovine respiratory disease: getting more from diagnostic results.

  2015cites this paper
• Pharmacokinetic and pharmacodynamic properties of gamithromycin in turkey poults with respect to Ornithobacterium rhinotracheale.

  2015influential citation
• Use of antimicrobials in the treatment of reproductive diseases in cattle and horses.

  2014cites this paper
• Workshop report: the 2012 antimicrobial agents in veterinary medicine: exploring the consequences of antimicrobial drug use: a 3-D approach.

  2014cites this paper
• Antibiotic Therapy in Critical Illness

  2012cites this paper